These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29560654)

  • 1. Olmesartan-associated enteropathy. A rare but easily treatable entity.
    Karakonstantis S; Tzagkarakis E; Giannikaki E; Paspatis G
    Acta Gastroenterol Belg; 2017; 80(4):541-543. PubMed ID: 29560654
    [No Abstract]   [Full Text] [Related]  

  • 2. [An unusual case of olmesartan induced enteropathy].
    Henry P; Dano H; Piessevaux H; Jouret-Mourin A
    Ann Pathol; 2019 Jun; 39(3):237-240. PubMed ID: 30712983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
    Choi EY; McKenna BJ
    Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
    Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
    Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
    [No Abstract]   [Full Text] [Related]  

  • 6. Olmesartan-associated enteropathy: results of a national survey.
    Marthey L; Cadiot G; Seksik P; Pouderoux P; Lacroute J; Skinazi F; Mesnard B; Chayvialle JA; Savoye G; Druez A; Parlier D; Abitbol V; Gompel M; Eoche M; Poncin E; Bobichon R; Colardelle P; Wils P; Salloum H; Peschard S; Zerbib F; Méresse B; Cerf-Bensussan N; Malamut G; Carbonnel F
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1103-9. PubMed ID: 25199794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
    Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal: Olmesartan-induced enteropathy.
    Shahzad MA; Harding D; Ruszkiewicz A; Tran E; England G; Philpott H
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1691. PubMed ID: 29968297
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
    Sáez González E; Díaz Jaime FC; Del Val Antoñana A
    Rev Esp Enferm Dig; 2016 Oct; 108(10):685-686. PubMed ID: 27109007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enteropathy by olmesartan].
    Téllez Villajos L; Crespo Pérez L; Cano Ruiz A; Moreira Vicente V
    Med Clin (Barc); 2015 Feb; 144(3):140-1. PubMed ID: 25194976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sprue-like enteropathy in the elderly treated with olmesartan].
    Calvo Beguería E; Martinez Huguet C; Gonzalez García MP; Omiste SanVicente T
    Rev Esp Geriatr Gerontol; 2017; 52(4):223-224. PubMed ID: 28277303
    [No Abstract]   [Full Text] [Related]  

  • 12. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.
    Scialom S; Malamut G; Meresse B; Guegan N; Brousse N; Verkarre V; Derrieux C; Macintyre E; Seksik P; Savoye G; Cadiot G; Vuitton L; Marthey L; Carbonnel F; Cerf-Bensussan N; Cellier C
    PLoS One; 2015; 10(6):e0125024. PubMed ID: 26101883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2016 May; 25(171):130-1. PubMed ID: 27280200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enteropathy associated with chronic use of olmesartan].
    Téllez A; Pellicé M; Llobell A; Milisenda JC
    Med Clin (Barc); 2015 Feb; 144(3):139-40. PubMed ID: 24930862
    [No Abstract]   [Full Text] [Related]  

  • 16. Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.
    Makri A; Florentin M; Elisaf MS; Liamis G
    Curr Drug Saf; 2019; 14(3):238-241. PubMed ID: 30848210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Olmesartan-associated Sprue-like Enteropathy.
    Nagashima K; Katsurada T; Sakamoto N
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):A45-A46. PubMed ID: 29247793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
    Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
    An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
    Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
    Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
    [No Abstract]   [Full Text] [Related]  

  • 20. A Clinical Approach to Chronic Diarrhea.
    Dutra B; Siddiqui S; Everett J
    Gastroenterology; 2022 Mar; 162(3):707-709. PubMed ID: 34331913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.